Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Abeona Therapeutics Inc. (NASDAQ: ABEO)
ABEO Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
252.70%
ABEO Stock Analysis
ABEO
PE Ratio:
5.8
ABEO
PEG Ratio:
Not Available
ABEO
Forward EPS Growth (12 month):
0.00%
ABEO
PS Ratio:
22.2
ABEO
PSG Ratio:
0.2
ABEO
Forward Revenue Growth (12 month):
138.70%
ABEO Articles
No data was found